Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 2;25(1):983.
doi: 10.1186/s12885-025-14315-5.

Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line

Affiliations

Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line

Masoumeh Saberpour et al. BMC Cancer. .

Abstract

Background: Colorectal cancer (CRC) has emerged as a global health concern, as evidenced by its position as the second leading cause of cancer-related mortality. This underscores the necessity for effective disease management strategies. The present study aims to assess the impact of chitosan nanoparticles (CSNP) conjugated with the Lactobacillus acidophilus secretome (CSNP/L.a-sup), on the signaling pathways associated with CRC.

Methods: The CSNP/L.a-sup was prepared using an ionic gelation procedure, and its particle size, surface charge, and morphology were evaluated using dynamic light scattering, zeta potential, and scanning electron microscopy. The encapsulation efficiency (EE) and the protein released from CSNP/L.a-sup were assayed using a BCA assay kit. CSNP/L.a-sup toxicity on colon adenocarcinoma (Caco-2) and human dermal fibroblasts (HDF) cells was assessed via the MTT assay. The expression levels of CRC signaling pathway genes were examined using real-time polymerase chain reaction (PCR).

Results: The size of CSNP/L.a-sup was detected at 478.6 ± 219.9 nm, with a surface charge of -8.9 mV. The protein released from CSNP/L.a-sup was observed 76% at pH ~ 6.8 after 48 h, with EE of 74.6%. The viability of Caco-2 and HDF cells against CSNP/L.a-sup was found to be 85.5% and 92.6%, respectively. The uptake of CSNP/L.a-sup by Caco-2 cells occurs in a time-dependent manner, with initial absorption observed within 1 h and substantial internalization achieved after 3 h. CSNP/L.a-sup led to a significant decrease in the expression of β-Catenin, TGF-α, and TGF-β genes, with respective changes of 0.42, 0.79, and 0.16-fold. In contrast, CSNP/L.a-sup led to a significant increase in the expression of PTEN and caspase-9 suppressor genes, with changes of 42.1 and 114.3-fold, respectively. The inhibitory effect of CSNP/L.a-sup on TGF-α gene expression appears to be more closely associated with the CSNP compartment, while the enhancing effect of CSNP/L.a-sup on PTEN gene expression is linked to L.a-sup.

Conclusion: This investigation signifies an inaugural exploration into the potential of a combination therapy comprising secretome of probiotic bacteria and chitosan nanostructures. This approach constitutes a substantial advancement in the field of developing efficacious treatment strategies, offering novel insights into the management of CRC.

Keywords: Lactobacillus acidophilus; Anti-cancer; Chitosan nanoparticle; Colorectal cancer; Signaling pathways.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This project has been approved by the Ethic Committee of Tarbiat Modares University (code: IR.MODARES.REC.1401.253). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Characterization of CSNP and CSNP/L.a-sup using DLS method. Size distribution of CSNP (A) and CSNP/L.a-sup (B). Surfaces charge of CSNP (C) and CSNP/L.a-sup (D)
Fig. 2
Fig. 2
SEM images of CSNP (A) and CSNP/L.a-sup (B). Entrapment efficiency (EE) of CSNP/L.a-sup (C). In-vitro L.a-sup release profile from CSNP/L.a-sup at (blue curve; pH ~ 1.8), (red curve; pH ~ 6.8), and (green curve; pH ~ 7.4) for 48 h, illustrating sustained and controlled release of L.a-sup (D)
Fig. 3
Fig. 3
Rhodamine-B labeled Caco-2 cells for cellular uptake. CSNP/L.a-sup examined by bright (A), fluorescence (B), and merge (C) images of CSNP/L.a-sup after 1 h, and bright (D), fluorescence (E), merge (F) images of CSNP/L.a-sup after 2 h
Fig. 4
Fig. 4
Caco-2 (A) and HDF (B) cells viability after exposure to CSNP/L.a-sup for 24 h
Fig. 5
Fig. 5
The fold changes in expression of genes related to CRC signaling pathways in Caco-2 cells after exposure with L.a-sup, CSNP, and CSNP/L.a-sup using real-time PCR, representing β-Catenin (A), TGF-β (B), TGF-α (C), Bcl2 (D). Values are presented as the mean ± SD of triplicate independent tests, *p <.0156, **p <.0018, ***p <.0003, and ****p <.0001 indicate statistically significant
Fig. 6
Fig. 6
The fold changes in expression of genes related to CRC signaling pathways in Caco-2 cells after exposure with L.a-sup, CSNP, and CSNP/L.a-sup using real-time PCR, representing TLR4 (A), CEA (B) Gli2 (C), and HES1 (D). Values are presented as the mean ± SD of triplicate independent tests. * p <.0101, ***p <.0003, and ****p <.0001 indicate statistically significant
Fig. 7
Fig. 7
The fold changes in expression of genes related to CRC signaling pathways in Caco-2 cells after exposure with L.a-sup, CSNP, and CSNP/L.a-sup using real-time PCR, representing PI3K (A), IL-6 (B), caspase-9 (C), and PTEN (D). Values are presented as the mean ± SD of triplicate independent tests. **p <.0030, ***p <.0007 and ****p <.0001 indicate statistically significant

Similar articles

References

    1. Koveitypour Z, Panahi F, Vakilian M, Peymani M, Seyed Forootan F, Nasr Esfahani MH, Ghaedi K. Signaling pathways involved in colorectal cancer progression. Cell Bioscience. 2019;9(1):97. - PMC - PubMed
    1. Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, et al. Rising incidence of early-onset colorectal cancer—A call to action. Nat Reviews Clin Oncol. 2021;18(4):230–43. - PMC - PubMed
    1. Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, et al. Cancer in Iran 2008 to 2025: recent incidence trends and short‐term predictions of the future burden. Int J Cancer. 2021;149(3):594–605. - PubMed
    1. Alzahrani SM, Al Doghaither HA, Al-Ghafari AB. General insight into cancer: an overview of colorectal cancer. Mol Clin Oncol. 2021;15(6):271. - PMC - PubMed
    1. Rahmati A, Homayouni Tabrizi M, Karimi E, Zarei B. Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha Terpineol in colon cancer. J Biomater Sci Polym Ed. 2022;33(10):1289–307. - PubMed

MeSH terms